Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 12, 2019
Patent Application Number
16245654
Date Filed
January 11, 2019
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compositions for the activation of PKR are provided, as well as therapeutic administration of the compositions for the treatment of pyruvate kinase-related medical conditions, such as pyruvate kinase deficiency (PKD).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
